A patient with a pituitary adenoma secreting follicle-stimulating hormone with coexistent primary hyperaldosteronism is described. After his second transsphenoidal surgery, the patient developed a Staphylococcus aureus pituitary abscess. Symptoms improved after abscess drainage. Subsequent cabergoline therapy arrested the deterioration of symptoms, and decreased serum follicle-stimulating hormone concentrations. Cabergoline may be a useful treatment for aggressively growing non-prolactin-secreting pituitary adenomas.
Pituitary adenomas secreting follicle-stimulating hormone (FSH) are uncommon and often present at a late stage with aggressive tumour growth. Their management can be difficult. Despite most non-functioning pituitary tumours expressing membrane-bound dopamine receptors,' the usefulness of dopamine agonists in non-prolactin-secreting pituitary adenomas remains uncertain. 2 We present a patient with a rapidly growing pituitary adenoma secreting FSH which appeared to be sensitive to the dopamine agonist cabergoline.
Case report
A 54-year-old man had an FSH-secreting pituitary adenoma removed by transsphenoidal surgery. Baseline serum FSH concentration was 144 U/I and tissue immunohistochemistry was positive for FSH and negative for the other pituitary hormones, including prolactin. Postoperatively, the patient required hydrocortisone and testosterone. Two years after surgery and a course of radiotherapy, transsphenoidal resection was repeated because FSH concentrations remained elevated (>40 U/1) and computed tomography (CT) demonstrated persistent tumour within the enlarged sella.
The serum FSH concentration was lower than previously, but remained elevated at 29.1 U/I and the patient required thyroxine replacement.
Four months after repeat surgery the patient was admitted with decreasing vision, worsening headaches and eye pressure. He was drowsy, had a low grade pyrexia (37.6C), and bitemporal hemianopia. Blood cultures were sterile and magnetic resonance imaging (MRI) demonstrated a large heterogenous pituitary mass with suprasellar extension into the third ventricle. A Staphylococcus aureus pituitary abscess was drained via subfrontal craniotomy. The patient was given intravenous and then oral flucloxacillin (2g qid) for four months. The headaches and vision improved and he was less lethargic.
Over the following six months the headaches and lethargy recurred, accompanied by decreasing visual acuity. The serum FSH concentration remained high (26 U/l), and there was no significant change in appearance on MRI. Octreotide was not tolerated and cabergoline 0.5 mg twice weekly was started. Serum FSH concentration decreased to 2.5 U/I after three months of treatment, and was 2.1 U/l after eight months (figure). During this time prolactin concentrations decreased from 773 to 42 U/l, and there was no further change in appearance of the pituitary on MRI. Headaches resolved and vision stabilised.
The patient had been treated for hypertension for over 20 years. Further investigations revealed a supine aldosterone:renin ratio of 2185 nmol/h/ng and a standing ratio of 4950 nmol/h/ng, suggestive of primary hyperaldosteronism. CT scan showed a 5-mm nodule on the left adrenal. 
